Filtrar por Last updated date SelectDespués deAntes deFrom - To Date Fecha de final Esta semana Este mes la semana pasada El mes pasado Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationMedical devicesScientific adviceMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate usePRIMECareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Deje este campo en blanco Filter Resultados (3846) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Deje este campo en blanco Committee for veterinary medicinal products: 65th meeting 19 Abril 2001Press releaseVeterinary EMEA Public Statement on the Recommendation to suspend the marketing authorisation for Orlaam (Levaceetylmethadol) in the European Union 19 Abril 2001News 12th meeting of the Committee for Orphan Medicinal Products 17 Abril 2001Press releaseHumanRare diseases 1st EMEA workshop for patients' organisations on Orphan Medicinal Products 5 Abril 2001Press releaseHumanRare diseases 69th meeting of the Committee for Proprietary Medicinal Products (CPMP) 3 Abril 2001Press release 11th meeting of the Committee for Orphan Medicinal Products 28 Marzo 2001Press releaseHumanRare diseases Meeting of the EMEA working party on herbal medicinal products 13 - 14 March 2001 23 Marzo 2001Press releaseHerbal Committee for veterinary medicinal products: 64th meeting 15 Marzo 2001Press releaseVeterinary European Medicines Agency public statement on Leflunomide (Arava) - Severe and serious hepatic reactions 12 Marzo 2001NewsMedicines 68th meeting of the Committee for Proprietary Medicinal Products (CPMP) 6 Marzo 2001Press release 1 … 361 362 363 364 365 Page 365 of 385 366 367 368 369 … 385
EMEA Public Statement on the Recommendation to suspend the marketing authorisation for Orlaam (Levaceetylmethadol) in the European Union 19 Abril 2001News
12th meeting of the Committee for Orphan Medicinal Products 17 Abril 2001Press releaseHumanRare diseases
1st EMEA workshop for patients' organisations on Orphan Medicinal Products 5 Abril 2001Press releaseHumanRare diseases
11th meeting of the Committee for Orphan Medicinal Products 28 Marzo 2001Press releaseHumanRare diseases
Meeting of the EMEA working party on herbal medicinal products 13 - 14 March 2001 23 Marzo 2001Press releaseHerbal
European Medicines Agency public statement on Leflunomide (Arava) - Severe and serious hepatic reactions 12 Marzo 2001NewsMedicines